COVIDonneur - SARS-CoV-2 seroprevalence study in the blood donor population

Head :
Gallian Pierre, Emerging Viruses Units, 20-21 Boulevard Jean Moulin, 13005 Marseille

Last update : 05/06/2021 | Version : 1 | ID : 73556

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name SARS-CoV-2 seroprevalence study in the blood donor population
Sign or acronym COVIDonneur
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation dossier RIPH : 20.04.28.41321
General Aspects
Medical area Infectious diseases
Study in connection with Covid-19 Yes
Keywords blood donors, serology prevalence, SARS-CoV-2
Scientific investigator(s) (Contact)
Name of the director Gallian
Surname Pierre
Address Etablissement Français du Sang, 20 avenue du Stade de France, 93128 La Plaine Saint Denis
Unit Emerging Viruses Units, 20-21 Boulevard Jean Moulin, 13005 Marseille
Organization French National Blood Service (EFS)
Collaborations
Funding
Funding status Public
Details ANR funding
Governance of the database
Sponsor(s) or organisation(s) responsible French National Blood Service (EFS)
Organisation status Public
Presence of scientific or steering committees No
Additional contact
Name of the contact Bonneaudeau
Surname Brigitte
Email brigitte.bonneaudeau@efs.sante.fr
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database objective
Main objective Estimate the seroprevalence of SARS-CoV-2 infection in the French blood donor population (18-70 years) in different geographical zones (mainland France and overseas departments), at different times in the epidemic, so as to model the progression of the epidemic
Inclusion criteria Accepted blood donors
aged 18 to 70 years.
in the geographical zones of interest
having agreed to the use of their samples for research

Plasma samples > 500 µL in volume
Population type
Age Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Population covered General population
Pathology
Gender Male
Woman
Geography area National
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Date of last collection (YYYY or MM/YYYY) 2021
Size of the database
Size of the database (number of individuals) [10 000-20 000[ individuals
Data
Database activity Current data collection
Type of data collected Biological data
Administrative data
Presence of a biobank Yes
Contents of biobank Plasma
Procedures
Followed pathology
Links to administrative sources No
Promotion and access
Promotion
Link to the document https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362788/
Description Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. Gallian P, Pastorino B, Morel P, Chiaroni J, Ninove L, de Lamballerie X.Antiviral Res. 2020 Sep;181:104880
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05